Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabetes complications, but many Latinx adolescents, who make up the largest marginalized ethnic group of youth with T1D in California, use these devices less often and have less optimal glucose control compared to White youth. In phase 1 of this project, we worked directly with Latinx youth, their families, and diabetes care team members in California to develop DREAM, Device use Reimagined through Education And Mentorship, a virtual peer group (VPG) intervention that will encourage and support the use of diabetes devices in Latinx adolescents with T1D. The goals for phase 2 (intervention) of this project are to evaluate the feasibility and acceptability of the stakeholder-informed VPG intervention, and evaluate clinical and person-centered outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 17
Healthy Volunteers: f
View:

• Adolescents 13-17 years old and their caregivers

• Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis

• Self-identify as Latina/o/x or other variations such as Hispanic

• Preferred language of English or Spanish

Locations
United States
California
University of California, Davis
RECRUITING
Davis
Children's Hospital Los Angeles
RECRUITING
Los Angeles
University of California, San Francisco
RECRUITING
San Francisco
Contact Information
Primary
Cristina Acosta Navarro, BA
cristina.acostanavarro@ucsf.edu
628-224-8436
Backup
Jenise C Wong, MD, PhD
Jenise.Wong@ucsf.edu
415-476-3316
Time Frame
Start Date: 2024-10-11
Estimated Completion Date: 2026-05-31
Participants
Target number of participants: 120
Treatments
Experimental: Intervention
Virtual peer groups (VPGs)~Six different VPGs topics will be offered. Each VPG topic will be presented separately to youth and caregivers, in Spanish and English. Frequency of scheduling for each VPG will vary on a month-to-month basis depending on the distribution of current enrollees who have not yet discussed that topic and the availability of the relevant facilitators.~In-Person Events~Optional in-person events may be offered quarterly during the 6-12 month study participation period.
No_intervention: Comparator Group
An equal number of eligible non-enrolled patients at each site will be selected and matched to the enrolled cohort based on age, language, HbA1c, insurance type, and diabetes technology use at a population level.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Children's Hospital Los Angeles, University of California, Davis
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov